Literature DB >> 24488186

Experience of a high-risk aortic valve clinic in Ireland.

K E O'Sullivan1, S A Early, I Casserly, Z Chugtai, D Sugrue, J Hurley.   

Abstract

BACKGROUND: The advent of transcatheter aortic valve implantation (TAVI) has broadened the management options for severe aortic stenosis. The indications for TAVI are narrow. Selecting those that will benefit most from this intervention warrants careful consideration and input from cardiologists, anaesthetists and cardiac surgeons familiar with TAVI and surgical aortic valve replacement (SAVR). AIMS: The aims of this paper were to assess the feasibility of establishing a high-risk aortic clinic in Ireland, and report stratification of the referred group into those suitable for SAVR, TAVI and conservative management.
METHODS: Patient data was prospectively collected by a dedicated clinical nurse specialist. ANOVA was used to assess variance in means between groups. Analyses were performed using IBM SPSS v20 (Armonk, NY: IBM Corp.).
RESULTS: A total of 105 patients were assessed. Eighty-five patients were deemed suitable for TAVI, 9 (10.5 %) died awaiting the procedure and a further 6 (7 %) declined intervention. Eleven (10.5 %) underwent conventional SAVR, 1 (0.9 %) a balloon valvuloplasty, 4 (3.8 %) entered surveillance and 4 (3.8 %) were declined treatment.
CONCLUSIONS: Establishment of a high-risk aortic clinic is feasible in the Irish context. The advent of TAVI has reduced the proportion of patients denied intervention to a minority. Despite being considered high risk, a number of patients were suitable candidates for SAVR. Measuring frailty continues to provide a challenge; a TAVI-specific frailty assessment tool would be advantageous to patient stratification.

Entities:  

Mesh:

Year:  2014        PMID: 24488186     DOI: 10.1007/s11845-014-1071-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  23 in total

1.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.

Authors:  F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

2.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

Review 3.  The natural history of aortic valve stenosis.

Authors:  D Horstkotte; F Loogen
Journal:  Eur Heart J       Date:  1988-04       Impact factor: 29.983

Review 4.  Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey.

Authors:  Alain Cribier
Journal:  Arch Cardiovasc Dis       Date:  2012-03-16       Impact factor: 2.340

Review 5.  Transcatheter aortic valve implantation: our vision of the future.

Authors:  Alec Vahanian; Dominique Himbert; Eric Brochet; Jean-Pol Depoix; Bernard Iung; Patrick Nataf
Journal:  Arch Cardiovasc Dis       Date:  2012-03-16       Impact factor: 2.340

6.  Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry.

Authors: 
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

7.  Frailty in patients affected by atrial fibrillation.

Authors:  A Polidoro; F Stefanelli; M Ciacciarelli; A Pacelli; D Di Sanzo; C Alessandri
Journal:  Arch Gerontol Geriatr       Date:  2013-05-23       Impact factor: 3.250

8.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

9.  Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis.

Authors:  C M Otto; M C Mickel; J W Kennedy; E L Alderman; T M Bashore; P C Block; J A Brinker; D Diver; J Ferguson; D R Holmes
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

10.  Long-term relative survival rates after heart valve replacement.

Authors:  D Lindblom; U Lindblom; J Qvist; H Lundström
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

View more
  1 in total

Review 1.  Advances in the management of severe aortic stenosis.

Authors:  K E O'Sullivan; S Bargenda; D Sugrue; J Hurley
Journal:  Ir J Med Sci       Date:  2016-02-17       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.